Jordan’s Mideast Drug-Export Dominance Faces Local Challenges
This article was originally published in PharmAsia News
Executive Summary
Jordan’s claim to the leading pharmaceutical market in the Middle East could be in jeopardy if it fails to increase its exports, according to Jordan’s FDA Director General Hayel Obeidat.
You may also be interested in...
Radical Shake-Up In Store For Entire EU Pharma Legislation
The EU pharmaceutical strategy published on 25 November will be the first step in a “complete overhaul” of the medicines legislative framework to be proposed in about two years’ time, says the European Commission.
EU Pharma Strategy Will Remove Barriers And Bolster Competition
The European Commission’s newly-published Pharmaceutical Strategy features a range of proposals related to generics and biosimilars, including “targeted policies” to improve competition, remove barriers and increase uptake.
Pfizer Faces 15-Year Wait On US Adrenalin Generic
Pfizer’s efforts to circumvent two US patents shielding Par’s Adrenalin (epinephrine) have again ended in failure, following a ruling by the US Court of Appeals for the Federal Circuit.
Need a specific report? 1000+ reports available
Buy Reports